SCHEMBL758318

SCHEMBL758318

COc1ccc2c(c1)CCC2NC(=O)c1ccc(-n2cnc(C)c2)c(OC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.51
PDE4B Q07343 1/20 0.51
PDE4C Q08493 1/20 0.51
PDE4D Q08499 1/20 0.51
PSEN1 P49768 8/20 0.50
PSEN2 P49810 8/20 0.50
APH1B Q8WW43 8/20 0.50
NCSTN Q92542 8/20 0.50
APH1A Q96BI3 8/20 0.50
PSENEN Q9NZ42 8/20 0.50
ROCK2 O75116 1/20 0.47
HPGDS O60760 1/20 0.47
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
WDR5 P61964 2/20 0.44
PDE10A Q9Y233 1/20 0.44
SLC5A7 Q9GZV3 1/20 0.44
KCNH2 Q12809 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL757612 0.85 PSEN1 (0.57) PDE4APDE4BPDE4CPDE4DPSEN1
SCHEMBL6853438 0.84 PDE4A (0.58) PDE4APDE4BPDE4CPDE4DPSEN1
SCHEMBL761019 0.80 PSEN1 (0.50) PDE4APDE4BPDE4CPDE4DPSEN1
SCHEMBL5273125 0.79 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DROCK2
SCHEMBL5277673 0.79 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DROCK2
SCHEMBL31157569 0.79 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DROCK2
SCHEMBL760378 0.79 PSEN1 (0.57) PDE4APDE4BPDE4CPDE4DPSEN1
SCHEMBL6852850 0.78 PSEN1 (0.58) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1239307 0.77 PDE4A (0.49) PDE4APDE4BPDE4CPDE4DPSEN1
SCHEMBL1239305 0.77 PDE4A (0.49) PDE4APDE4BPDE4CPDE4DPSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120053165-A1 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators PFIZER INC. (US) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053165-A1 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators BACE1, BACE2, PSEN1 PDE4A 622/4885PDE4B 388/4885PDE4C 1070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.